Table 4

Pain-related diagnoses in patients with new pregabalin/gabapentin (P/G) prescriptions in 2015 (n=25 251)

Pain-related diagnosesNumber of insured persons%
A1Non-neuropathic pain (exclusive)295111.7
B2Typical neuropathic pain disorder (exclusive)
(demonstrable benefit of a P/G therapy)
12184.8
C3Pain with possible neuropathic or partial-neuropathic cause (exclusive)
(no demonstrable benefit of P/G)
302512.0
D1+212955.1
E1+310 75642.6
F2+310104.0
G1+2+3299011.8
Hneither 1, 2 nor 320067.9